Cargando…
The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
OBJECTIVE: Recent studies have reported conflicting results on the correlation between metformin use and outcomes in patients with colorectal cancer (CRC). A meta-analysis was performed to evaluate the efficacy of metformin therapy on the prognosis of CRC patients with type 2 diabetes mellitus (T2DM...
Autores principales: | Tian, Shan, Lei, Hong-Bo, Liu, Yu-Lan, Chen, Yan, Dong, Wei-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643786/ https://www.ncbi.nlm.nih.gov/pubmed/29063073 http://dx.doi.org/10.1016/j.cdtm.2017.06.001 |
Ejemplares similares
-
Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis
por: Li, Jingtao, et al.
Publicado: (2017) -
Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis
por: Li, Junshan, et al.
Publicado: (2015) -
Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis
por: Dong, Yi-Wei, et al.
Publicado: (2017) -
Thiazolidinediones versus metformin on improving abnormal liver enzymes in patients with type 2 diabetes mellitus: a meta-analysis
por: Xu, Chunmei, et al.
Publicado: (2018) -
Prognostic role of metformin in diabetes mellitus type 2 patients with hepatocellular carcinoma: A systematic review and meta-analysis
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2023)